Prot# CYC682-06-05 (A2): A Randomized Phase II Study of Oral Sapacitabine in Patients with Advanced Cutaneous T-Cell Lymphoma

  • Kuzel, Timothy Michael (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date10/7/08 → 10/7/11

Funding

  • Cyclacel Pharmaceuticals, Inc. (CYC682-06-05 (A2))
View all
View less